Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.20.1
Stockholders' Equity (Details) - Options [Member]
3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options, Outstanding and expected to vest, Beginning balance | shares 3,615,602
Number of Options, Granted | shares 600,000
Number of Options, Exercised | shares (2,434)
Number of Options, Forfeited | shares (215,312)
Number of Options, Outstanding and expected to vest, Ending balance | shares 3,997,856
Number of Options, Options exercisable | shares 834,719
Weighted Average Exercise Price Per Share, Outstanding and expected to vest - Beginning balance | $ / shares $ 19.96
Weighted Average Exercise Price Per Share, Granted | $ / shares 39.24
Weighted Average Exercise Price Per Share, Forfeited | $ / shares 30.00
Weighted Average Exercise Price Per Share, Exercised | $ / shares 21.58
Weighted Average Exercise Price Per Share, Outstanding and expected to vest - Ending balance | $ / shares 22.76
Weighted Average Exercise Price Per Share, Options exercisable | $ / shares $ 9.61
Weighted Average Remaining Contractual Term (Years), Beginning Outstanding 9 years 2 months 12 days
Weighted Average Remaining Contractual Term (Years), Granted 9 years 11 months 15 days
Weighted Average Remaining Contractual Term (Years), Issued
Weighted Average Remaining Contractual Term (Years), Ending Outstanding 9 years 18 days
Weighted Average Remaining Contractual Term (Years), Options exercisable 7 years 9 months 25 days
Aggregate Intrinsic Value, Outstanding and expected to vest - Beginning balance | $ $ 74,837,043
Aggregate Intrinsic Value, Outstanding and expected to vest, Granted | $
Aggregate Intrinsic Value, Outstanding and expected to vest, Forfeited | $
Aggregate Intrinsic Value, Outstanding and expected to vest, Exercised | $
Aggregate Intrinsic Value, Outstanding and expected to vest - Ending balance | $ 60,969,194
Aggregate Intrinsic Value, Options exercisable | $ $ 21,228,752